The addition of dupilumab enhances desensitization and reduces gastrointestinal symptoms in omalizumab-facilitated multi-allergen oral immunotherapy in the COMBINE trial

Journal of Allergy and Clinical Immunology 2026

View at publisher
Authors: Sayantani Sindher, Andrew J. Long, Maria Garcia-llorett, Stephanie Leonard, Emily J. Mastej, Dinara Bogetic, Ella Sandrine Parsons, Shu Cao, Malia D Beaulieu, Margaret A. Woch, Kristine Martinez, Olivia Raeber
+24 more Brent Anderson, Stacey Skura Zedeck, A. Grissinger, Ji Hyun Choi, Reyna Sharma, Marleni Albarran, Jackson P. Schuetz, Andrea C. Fernandes, Catherine Feight, Andrew R. Chin, Julia Tang, Alyssa Parry, Elizabeth A. Kiernan, Susan Stefanac Laubach, Robert John Tibshirani, Scott Dexter Boyd, Joy Laurienzo Panza, Julian Poyser, Manisha Desai, Lisa M. Wheatley, Alkis G. Togias, Stephen Joseph Galli, Kari Christine Nadeau, R. Sharon Chinthrajah
DOI: 10.1016/j.jaci.2025.12.917
Cited by: 0

Fields of Study & Subjects

Food Allergy and Anaphylaxis Research Allergic Rhinitis and Sensitization Eosinophilic Esophagitis

Publication details

Journal / source
Journal of Allergy and Clinical Immunology
Volume
157
Issue
2
Pages
AB415–AB415
Publication date
1 February 2026
Language
EN